JPM has a vice lock on all things Clinuvel, trying to squeeze a few bucks and break the resolve of long term holders. Insurance companies paying for Vitiligo changed the direction of the company. This new path was going to require 5 years before 1/2 billion in revenues are to be realized. JPM saw an opportunity...they deployed plants at every turn, and offers to match each bid. This will reverse sometime within the next 18 months as monster revenues become inevitable. The downside here is a dollar or 2? The upside...several 100%.
CUV Price at posting:
$10.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)